The SCFβ-TRCP–ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro
暂无分享,去创建一个
Stephen J. Elledge | S. Elledge | P. Beer-Romero | J. Harper | P. Strack | J. W. Harper | P Beer-Romero | Jeffrey T. Winston | P Strack | Chu Cy | J. Winston | Chuang Cy
[1] M. Pagano,et al. The human F box protein β-Trcp associates with the Cul1/Skp1 complex and regulates the stability of β-catenin , 1999, Oncogene.
[2] Stephen J. Elledge,et al. The univector plasmid-fusion system, a method for rapid construction of recombinant DNA without restriction enzymes , 1998, Current Biology.
[3] R. Gaynor,et al. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β , 1998, Nature.
[4] E. Zandi,et al. IKK-γ is an essential regulatory subunit of the IκB kinase complex , 1998, Nature.
[5] P. Baeuerle,et al. IKAP is a scaffold protein of the IκB kinase complex , 1998, Nature.
[6] Y. Marikawa,et al. β-TrCP is a negative regulator of the Wnt/β-catenin signaling pathway and dorsal axis formation in Xenopus embryos , 1998, Mechanisms of Development.
[7] Ebrahim Zandi,et al. Direct Phosphorylation of IκB by IKKα and IKKβ: Discrimination Between Free and NF-κB-Bound Substrate , 1998 .
[8] G. Courtois,et al. Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB Activation , 1998, Cell.
[9] R. Deshaies,et al. Human CUL1 forms an evolutionarily conserved ubiquitin ligase complex (SCF) with SKP1 and an F-box protein. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[10] E. Gelmann,et al. β-Catenin Mutations in Human Prostate Cancer , 1998 .
[11] M. Tyers,et al. Combinatorial control in ubiquitin-dependent proteolysis: don't Skp the F-box hypothesis. , 1998, Trends in genetics : TIG.
[12] Y. Xiong,et al. Human CUL-1, but not other cullin family members, selectively interacts with SKP1 to form a complex with SKP2 and cyclin A. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[13] C. Scheidereit,et al. Signal-dependent degradation of IκBα is mediated by an inducible destruction box that can be transferred to NF-κB, Bcl-3 or p53 , 1998 .
[14] M. Hochstrasser. There's the rub: a novel ubiquitin-like modification linked to cell cycle regulation. , 1998, Genes & development.
[15] T. Sugimura,et al. High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. , 1998, Cancer research.
[16] Akira Kikuchi,et al. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .
[17] D. Thomas,et al. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. , 1998, Molecular cell.
[18] M. Tyers,et al. Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box proteincomplexes that regulate cell division and methionine biosynthesis in yeast. , 1998, Genes & development.
[19] G. Struhl,et al. Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb , 1998, Nature.
[20] M. Gstaiger,et al. Association of human CUL‐1 and ubiquitin‐conjugating enzyme CDC34 with the F‐box protein p45SKP2: evidence for evolutionary conservation in the subunit composition of the CDC34–SCF pathway , 1998, The EMBO journal.
[21] A. Ciechanover,et al. Inhibition of NF‐κB cellular function via specific targeting of the IκB‐ubiquitin ligase , 1997 .
[22] Matthias Mann,et al. IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .
[23] Mike Rothe,et al. IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK , 1997 .
[24] Mike Tyers,et al. F-Box Proteins Are Receptors that Recruit Phosphorylated Substrates to the SCF Ubiquitin-Ligase Complex , 1997, Cell.
[25] R. Deshaies,et al. A Complex of Cdc4p, Skp1p, and Cdc53p/Cullin Catalyzes Ubiquitination of the Phosphorylated CDK Inhibitor Sic1p , 1997, Cell.
[26] E. Zandi,et al. The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.
[27] David M. Rothwarf,et al. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.
[28] R. Deshaies,et al. SIC1 is ubiquitinated in vitro by a pathway that requires CDC4, CDC34, and cyclin/CDK activities. , 1997, Molecular biology of the cell.
[29] D. Goeddel,et al. Identification and Characterization of an IκB Kinase , 1997, Cell.
[30] Jörg Stappert,et al. β‐catenin is a target for the ubiquitin–proteasome pathway , 1997 .
[31] Paul Polakis,et al. Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines , 1997, Science.
[32] Mark Peifer,et al. β-Catenin as Oncogene--The Smoking Gun , 1997, Science.
[33] K. Kinzler,et al. Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.
[34] Hans Clevers,et al. Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.
[35] M. Memo,et al. Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation , 1996, Science.
[36] Marty W. Mayo,et al. TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.
[37] David Baltimore,et al. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.
[38] Seamus J. Martin,et al. Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.
[39] Michael Karin,et al. Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.
[40] David Baltimore,et al. NF-κB: Ten Years After , 1996, Cell.
[41] D. White,et al. Rel/NF-kappaB/IkappaB proteins and cancer. , 1996, Oncogene.
[42] Stephen J. Elledge,et al. SKP1 Connects Cell Cycle Regulators to the Ubiquitin Proteolysis Machinery through a Novel Motif, the F-Box , 1996, Cell.
[43] M. Hochstrasser,et al. Protein Degradation or Regulation: Ub the Judge , 1996, Cell.
[44] T. Maniatis,et al. Site-Specific Phosphorylation of IκBα by a Novel Ubiquitination-Dependent Protein Kinase Activity , 1996, Cell.
[45] T. Maniatis,et al. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[46] A. Ciechanover,et al. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[47] T. Maniatis,et al. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. , 1995, Genes & development.
[48] P. Beer-Romero,et al. Reconstitution of p53-ubiquitinylation reactions from purified components: the role of human ubiquitin-conjugating enzyme UBC4 and E6-associated protein (E6AP). , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[49] S. Gerstberger,et al. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation , 1995, Science.
[50] M. Karin,et al. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B , 1995, Molecular and cellular biology.
[51] S. Elledge,et al. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells , 1995, Science.
[52] Martin Scheffner,et al. Protein ubiquitination involving an E1–E2–E3 enzyme ubiquitin thioester cascade , 1995, Nature.
[53] M. Kirschner,et al. Ubiquitination of the G1 cyclin Cln2p by a Cdc34p‐dependent pathway. , 1995, The EMBO journal.
[54] M. Hochstrasser. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. , 1995, Current opinion in cell biology.
[55] A. Baldwin,et al. Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[56] C. Stratowa,et al. Saccharomyces cerevisiae cdc15 mutants arrested at a late stage in anaphase are rescued by Xenopus cDNAs encoding N-ras or a protein with beta-transducin repeats , 1993, Molecular and cellular biology.
[57] A. Baldwin,et al. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation , 1993, Molecular and cellular biology.
[58] S. Ruben,et al. Erratum: IKB interacts with the nuclear localization sequences of the subunits of NF-KB: A mechanism for cytoplasmic retention (Genes and Development (1992) 6 (1899-1913)) , 1992 .
[59] S. Ruben,et al. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. , 1992, Genes & development.
[60] A. Friedman,et al. Loss of heterozygosity for 10q loci in human gliomas , 1992, Genes, chromosomes & cancer.
[61] F. Mitelman,et al. Cytogenetic analysis of 57 primary prostatic adenocarcinomas , 1992, Genes, chromosomes & cancer.
[62] P. Nowell,et al. Possible involvement of the chromosome region 10q24----q26 in early stages of melanocytic neoplasia. , 1988, Cancer genetics and cytogenetics.